Cargando…

Polypyrrole Nanoenzymes as Tumor Microenvironment Modulators to Reprogram Macrophage and Potentiate Immunotherapy

Nanozyme‐based tumor catalytic therapy has attracted widespread attention in recent years, but its therapeutic outcome is drastically diminished by species of nanozyme, concentration of substrate, pH value, and reaction temperature, etc. Herein, a novel Cu‐doped polypyrrole nanozyme (CuP) with trien...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Weiwei, Yu, Mian, Chen, Ting, Liu, Yuanqi, Yi, Yunfei, Huang, Chenyi, Tang, Jia, Li, Hanyue, Ou, Meitong, Wang, Tianqi, Wu, Meiying, Mei, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376744/
https://www.ncbi.nlm.nih.gov/pubmed/35678111
http://dx.doi.org/10.1002/advs.202201703
_version_ 1784768199617675264
author Zeng, Weiwei
Yu, Mian
Chen, Ting
Liu, Yuanqi
Yi, Yunfei
Huang, Chenyi
Tang, Jia
Li, Hanyue
Ou, Meitong
Wang, Tianqi
Wu, Meiying
Mei, Lin
author_facet Zeng, Weiwei
Yu, Mian
Chen, Ting
Liu, Yuanqi
Yi, Yunfei
Huang, Chenyi
Tang, Jia
Li, Hanyue
Ou, Meitong
Wang, Tianqi
Wu, Meiying
Mei, Lin
author_sort Zeng, Weiwei
collection PubMed
description Nanozyme‐based tumor catalytic therapy has attracted widespread attention in recent years, but its therapeutic outcome is drastically diminished by species of nanozyme, concentration of substrate, pH value, and reaction temperature, etc. Herein, a novel Cu‐doped polypyrrole nanozyme (CuP) with trienzyme‐like activities, including catalase (CAT), glutathione peroxidase (GPx), and peroxidase (POD), is first proposed by a straightforward one‐step procedure, which can specifically promote O(2) and ·OH elevation but glutathione (GSH) reduction in tumor microenvironment (TME), causing irreversible oxidative stress damage to tumor cells and reversing the redox balance. The PEGylated CuP nanozyme (CuPP) has been demonstrated to efficiently reverse immunosuppressive TME by overcoming tumor hypoxia and re‐educating macrophage from pro‐tumoral M2 to anti‐tumoral M1 phenotype. More importantly, CuPP exhibits hyperthermia‐enhanced enzyme‐mimic catalytic and immunoregulatory activities, which results in intense immune responses and almost complete tumor inhibition by further combining with αPD‐L1. This work opens intriguing perspectives not only in enzyme‐catalytic nanomedicine but also in macrophage‐based tumor immunotherapy.
format Online
Article
Text
id pubmed-9376744
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-93767442022-08-18 Polypyrrole Nanoenzymes as Tumor Microenvironment Modulators to Reprogram Macrophage and Potentiate Immunotherapy Zeng, Weiwei Yu, Mian Chen, Ting Liu, Yuanqi Yi, Yunfei Huang, Chenyi Tang, Jia Li, Hanyue Ou, Meitong Wang, Tianqi Wu, Meiying Mei, Lin Adv Sci (Weinh) Research Articles Nanozyme‐based tumor catalytic therapy has attracted widespread attention in recent years, but its therapeutic outcome is drastically diminished by species of nanozyme, concentration of substrate, pH value, and reaction temperature, etc. Herein, a novel Cu‐doped polypyrrole nanozyme (CuP) with trienzyme‐like activities, including catalase (CAT), glutathione peroxidase (GPx), and peroxidase (POD), is first proposed by a straightforward one‐step procedure, which can specifically promote O(2) and ·OH elevation but glutathione (GSH) reduction in tumor microenvironment (TME), causing irreversible oxidative stress damage to tumor cells and reversing the redox balance. The PEGylated CuP nanozyme (CuPP) has been demonstrated to efficiently reverse immunosuppressive TME by overcoming tumor hypoxia and re‐educating macrophage from pro‐tumoral M2 to anti‐tumoral M1 phenotype. More importantly, CuPP exhibits hyperthermia‐enhanced enzyme‐mimic catalytic and immunoregulatory activities, which results in intense immune responses and almost complete tumor inhibition by further combining with αPD‐L1. This work opens intriguing perspectives not only in enzyme‐catalytic nanomedicine but also in macrophage‐based tumor immunotherapy. John Wiley and Sons Inc. 2022-06-09 /pmc/articles/PMC9376744/ /pubmed/35678111 http://dx.doi.org/10.1002/advs.202201703 Text en © 2022 The Authors. Advanced Science published by Wiley‐VCH GmbH https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Zeng, Weiwei
Yu, Mian
Chen, Ting
Liu, Yuanqi
Yi, Yunfei
Huang, Chenyi
Tang, Jia
Li, Hanyue
Ou, Meitong
Wang, Tianqi
Wu, Meiying
Mei, Lin
Polypyrrole Nanoenzymes as Tumor Microenvironment Modulators to Reprogram Macrophage and Potentiate Immunotherapy
title Polypyrrole Nanoenzymes as Tumor Microenvironment Modulators to Reprogram Macrophage and Potentiate Immunotherapy
title_full Polypyrrole Nanoenzymes as Tumor Microenvironment Modulators to Reprogram Macrophage and Potentiate Immunotherapy
title_fullStr Polypyrrole Nanoenzymes as Tumor Microenvironment Modulators to Reprogram Macrophage and Potentiate Immunotherapy
title_full_unstemmed Polypyrrole Nanoenzymes as Tumor Microenvironment Modulators to Reprogram Macrophage and Potentiate Immunotherapy
title_short Polypyrrole Nanoenzymes as Tumor Microenvironment Modulators to Reprogram Macrophage and Potentiate Immunotherapy
title_sort polypyrrole nanoenzymes as tumor microenvironment modulators to reprogram macrophage and potentiate immunotherapy
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376744/
https://www.ncbi.nlm.nih.gov/pubmed/35678111
http://dx.doi.org/10.1002/advs.202201703
work_keys_str_mv AT zengweiwei polypyrrolenanoenzymesastumormicroenvironmentmodulatorstoreprogrammacrophageandpotentiateimmunotherapy
AT yumian polypyrrolenanoenzymesastumormicroenvironmentmodulatorstoreprogrammacrophageandpotentiateimmunotherapy
AT chenting polypyrrolenanoenzymesastumormicroenvironmentmodulatorstoreprogrammacrophageandpotentiateimmunotherapy
AT liuyuanqi polypyrrolenanoenzymesastumormicroenvironmentmodulatorstoreprogrammacrophageandpotentiateimmunotherapy
AT yiyunfei polypyrrolenanoenzymesastumormicroenvironmentmodulatorstoreprogrammacrophageandpotentiateimmunotherapy
AT huangchenyi polypyrrolenanoenzymesastumormicroenvironmentmodulatorstoreprogrammacrophageandpotentiateimmunotherapy
AT tangjia polypyrrolenanoenzymesastumormicroenvironmentmodulatorstoreprogrammacrophageandpotentiateimmunotherapy
AT lihanyue polypyrrolenanoenzymesastumormicroenvironmentmodulatorstoreprogrammacrophageandpotentiateimmunotherapy
AT oumeitong polypyrrolenanoenzymesastumormicroenvironmentmodulatorstoreprogrammacrophageandpotentiateimmunotherapy
AT wangtianqi polypyrrolenanoenzymesastumormicroenvironmentmodulatorstoreprogrammacrophageandpotentiateimmunotherapy
AT wumeiying polypyrrolenanoenzymesastumormicroenvironmentmodulatorstoreprogrammacrophageandpotentiateimmunotherapy
AT meilin polypyrrolenanoenzymesastumormicroenvironmentmodulatorstoreprogrammacrophageandpotentiateimmunotherapy